(PMT) PennyMac Mortgage - Overview
Stock: Mortgage-Backed Securities, Servicing Rights, Credit Transfers, Prime Loans
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 13.05% |
| Yield on Cost 5y | 15.67% |
| Yield CAGR 5y | -3.95% |
| Payout Consistency | 93.1% |
| Payout Ratio | 1.6% |
| Risk 5d forecast | |
|---|---|
| Volatility | 33.1% |
| Relative Tail Risk | -10.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.06 |
| Alpha | -8.22 |
| Character TTM | |
|---|---|
| Beta | 0.569 |
| Beta Downside | 0.661 |
| Drawdowns 3y | |
|---|---|
| Max DD | 24.23% |
| CAGR/Max DD | 0.28 |
Description: PMT PennyMac Mortgage January 19, 2026
PennyMac Mortgage Investment Trust (PMT) is a U.S. REIT that, through its subsidiary, invests primarily in residential mortgage-related assets. Its operations are divided into three strategic segments: Credit Sensitive Strategies (investing in credit risk transfer agreements and subordinate MBS), Interest Rate Sensitive Strategies (holding mortgage servicing rights, base and excess servicing spreads, agency and senior non-agency MBS, plus hedging interest-rate exposure), and Correspondent Production (originating, pooling, and selling newly originated prime loans, largely to government-sponsored enterprises).
The REIT structure allows PMT to avoid federal corporate income tax provided it distributes at least 90 % of taxable income, a requirement it has historically met. Incorporated in 2009 and headquartered in Westlake Village, California, PMT qualifies under the GICS sub-industry “Mortgage REITs.”
Key market drivers for PMT include the level of the 30-year Treasury yield (which influences mortgage rates and MBS spreads), the credit quality of the underlying loan pool, and the Fed’s monetary-policy stance on rate hikes. As of the most recent quarter, PMT’s dividend yield hovered around 9 % and its net asset value (NAV) had contracted roughly 15 % year-to-date, reflecting pressure from rising rates on interest-sensitive holdings.
Investors should monitor the forward curve of mortgage rates and the pace of new loan origination volumes, as these variables materially affect both the Credit Sensitive and Correspondent Production segments.
For a deeper quantitative breakdown, the ValueRay platform offers up-to-date metrics and scenario analysis.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 122.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.30 > 0.02 and ΔFCF/TA -25.42 > 1.0 |
| NWC/Revenue: -586.3% < 20% (prev -427.9%; Δ -158.4% < -1%) |
| CFO/TA -0.30 > 3% & CFO -5.53b > Net Income 122.0m |
| Net Debt (2.86b) to EBITDA (1.08b): 2.64 < 3 |
| Current Ratio: 0.08 > 1.5 & < 3 |
| Outstanding Shares: last quarter (87.0m) vs 12m ago 0.18% < -2% |
| Gross Margin: 83.38% > 18% (prev 0.85%; Δ 8253 % > 0.5%) |
| Asset Turnover: 3.25% > 50% (prev 6.18%; Δ -2.94% > 0%) |
| Interest Coverage Ratio: 0.05 > 6 (EBITDA TTM 1.08b / Interest Expense TTM 802.8m) |
Altman Z'' -1.19
| A: -0.16 (Total Current Assets 263.5m - Total Current Liabilities 3.27b) / Total Assets 18.53b |
| B: -0.03 (Retained Earnings -589.6m / Total Assets 18.53b) |
| C: 0.00 (EBIT TTM 40.2m / Avg Total Assets 15.79b) |
| D: -0.04 (Book Value of Equity -588.7m / Total Liabilities 16.65b) |
| Altman-Z'' Score: -1.19 = CCC |
What is the price of PMT shares?
Over the past week, the price has changed by +3.30%, over one month by -2.94%, over three months by +4.45% and over the past year by +1.84%.
Is PMT a buy, sell or hold?
- StrongBuy: 0
- Buy: 2
- Hold: 7
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PMT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13.5 | 10.5% |
| Analysts Target Price | 13.5 | 10.5% |
| ValueRay Target Price | 14.1 | 15.4% |
PMT Fundamental Data Overview February 01, 2026
P/E Forward = 7.1531
P/S = 1.8231
P/B = 0.7649
P/EG = 2.12
Revenue TTM = 512.6m USD
EBIT TTM = 40.2m USD
EBITDA TTM = 1.08b USD
Long Term Debt = 8.56b USD (from longTermDebt, last quarter)
Short Term Debt = 3.13b USD (from shortTermDebt, last quarter)
Debt = 3.13b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.86b USD (from netDebt column, last quarter)
Enterprise Value = 3.89b USD (1.03b + Debt 3.13b - CCE 263.5m)
Interest Coverage Ratio = 0.05 (Ebit TTM 40.2m / Interest Expense TTM 802.8m)
EV/FCF = -0.70x (Enterprise Value 3.89b / FCF TTM -5.53b)
FCF Yield = -142.1% (FCF TTM -5.53b / Enterprise Value 3.89b)
FCF Margin = -1079 % (FCF TTM -5.53b / Revenue TTM 512.6m)
Net Margin = 23.81% (Net Income TTM 122.0m / Revenue TTM 512.6m)
Gross Margin = 83.38% ((Revenue TTM 512.6m - Cost of Revenue TTM 85.2m) / Revenue TTM)
Gross Margin QoQ = 86.15% (prev -63.10%)
Tobins Q-Ratio = 0.21 (Enterprise Value 3.89b / Total Assets 18.53b)
Interest Expense / Debt = 7.31% (Interest Expense 228.4m / Debt 3.13b)
Taxrate = 36.30% (34.1m / 93.8m)
NOPAT = 25.6m (EBIT 40.2m * (1 - 36.30%))
Current Ratio = 0.08 (Total Current Assets 263.5m / Total Current Liabilities 3.27b)
Debt / Equity = 1.66 (Debt 3.13b / totalStockholderEquity, last quarter 1.88b)
Debt / EBITDA = 2.64 (Net Debt 2.86b / EBITDA 1.08b)
Debt / FCF = -0.52 (negative FCF - burning cash) (Net Debt 2.86b / FCF TTM -5.53b)
Total Stockholder Equity = 1.90b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.77% (Net Income 122.0m / Total Assets 18.53b)
RoE = 6.44% (Net Income TTM 122.0m / Total Stockholder Equity 1.90b)
RoCE = 0.38% (EBIT 40.2m / Capital Employed (Equity 1.90b + L.T.Debt 8.56b))
RoIC = 0.30% (NOPAT 25.6m / Invested Capital 8.43b)
WACC = 5.49% (E(1.03b)/V(4.15b) * Re(8.01%) + D(3.13b)/V(4.15b) * Rd(7.31%) * (1-Tc(0.36)))
Discount Rate = 8.01% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -2.22%
Fair Price DCF = unknown (Cash Flow -5.53b)
EPS Correlation: 55.01 | EPS CAGR: 25.43% | SUE: 0.38 | # QB: 0
Revenue Correlation: 28.43 | Revenue CAGR: 23.30% | SUE: -2.50 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.40 | Chg30d=-0.001 | Revisions Net=+5 | Analysts=7
EPS current Year (2026-12-31): EPS=1.61 | Chg30d=-0.012 | Revisions Net=+5 | Growth EPS=+63.0% | Growth Revenue=+28.4%
EPS next Year (2027-12-31): EPS=1.70 | Chg30d=-0.009 | Revisions Net=+2 | Growth EPS=+5.1% | Growth Revenue=+2.4%